# Addiction Psychiatry Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Joe Louis (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX002-SYN
- Date: 2026-07-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Naomi Featherstone-Ibe, MD
- Calendar frame: modern shifted

- Requested by: Desmond Achterberg-Cole, MD

## Reason for consultation

Persecutory thoughts and poor sleep for two months in a 55-year-old man, a retired heavyweight boxer, who uses cocaine most days and collapsed in the street two weeks ago. Please help decide whether this is a cocaine-induced psychosis, a primary psychotic disorder or a neurocognitive disorder, and advise on an antipsychotic, treatment for cocaine use disorder and safety. **S**

## History

Mr. Louis, a 55-year-old retired heavyweight boxer and Army veteran, is seen at the request of Dr. Achterberg-Cole one week after intake. He began using cocaine about a year ago at gatherings and then most days, more on trips for paid appearances. About two months ago he became convinced that people were following him and planned to harm him; he has never had such beliefs at other times, and he has no history of psychiatric treatment. He has used no cocaine for ten days. The beliefs are less intense but persist, and he sleeps about four hours. He has had no hallucinations, has not confronted anyone and has no thoughts of harming himself or others. He wants to stop using cocaine and to feel like himself, and he would like to keep his family out of it for now. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert; blood pressure 148/94, pulse 90; weight 101.0 kg |
| Neurological | No tremor, rigidity or abnormal movements (AIMS 0); gait normal |
| Psychiatric | Courteous and watchful; persecutory delusion held less firmly than a week ago; no hallucinations; oriented; insight partial; no suicidal or homicidal ideation |

BP 148/94 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 98% on room air; weight 101 kg; BMI 28.9 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Achterberg-Cole's intake note and safety assessment. Intake ECG (sinus tachycardia, left ventricular hypertrophy by voltage, QTc 436 ms), creatine kinase 262 U/L, blood count, metabolic panel, liver enzymes and hemoglobin A1c 5.5%, all normal. Urine drug test positive for cocaine, negative for fentanyl, other opioids, amphetamines, benzodiazepines and cannabis. TSH 1.9 and vitamin B12 486, normal. HIV, hepatitis C and syphilis negative; hepatitis B not immune. MoCA 25, PHQ-9 8, GAD-7 9, DAST-10 7, AUDIT-C 3. Brain MRI this morning: no contusion, microbleeds or mass; volume normal for age. Fasting lipids today: total cholesterol 204, HDL 44, LDL 128, triglycerides 160 mg/dL. Total cholesterol: 204 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol (calculated): 128 mg/dL (high); Triglycerides: 160 mg/dL (high). All results are synthetic.

## Assessment

1. **Cocaine use disorder, severe, with cocaine-induced psychotic disorder** (F14.250). Seven DSM-5-TR criteria make a severe cocaine use disorder. The delusions began during heavy use, he has never had psychotic symptoms without cocaine, they are already fading after ten days, and the examination, laboratory tests and MRI show no other cause: this is a cocaine-induced psychotic disorder. A primary psychotic disorder becomes likelier only if symptoms persist beyond about a month without cocaine, and the diagnosis of schizophrenia, which is made too often in Black men, should not be made on a first presentation like this. **S**
2. **Cognition after a long boxing career**. A MoCA of 25 after three hours of sleep and during active psychosis does not show a neurocognitive disorder; the MRI is normal. Traumatic encephalopathy syndrome is a research diagnosis under the NINDS consensus criteria, not a clinical one, and chronic traumatic encephalopathy can be confirmed only after death, so neither label belongs in his record. The MoCA should be repeated when he has slept well and been well for some weeks. **S**
3. **Antipsychotic**. Symptoms that persist after ten days without cocaine and keep him from sleeping justify an antipsychotic, as the ASAM/AAAP guideline advises. Aripiprazole at a low dose has little effect on weight, glucose, prolactin and the QT interval, which suits a man with raised blood pressure and a borderline lipid profile. Watch for akathisia. After a period of remission, a gradual taper is advised for a stimulant-induced psychosis. **S**
4. **Treatment of cocaine use disorder**. No medicine is approved by the FDA for cocaine use disorder. Contingency management is the treatment with the strongest evidence and should be the core of his plan, with cognitive behavioral therapy alongside it. The off-label options in the guideline, such as topiramate or bupropion, can wait while he does well, and the stimulant-based ones (modafinil, or topiramate with extended-release amphetamine) are unsafe after a psychosis and with high blood pressure. **S**
5. **Raised blood pressure and cardiovascular risk** (R03.0). Cocaine raises blood pressure and the risk of heart attack, stroke, arrhythmia and aortic dissection. His blood pressure remains raised ten days after his last use, and the ECG shows left ventricular hypertrophy by voltage, so hypertension is likely; it should be confirmed with home readings once he has been without cocaine for some weeks. Beta-blockers are best avoided while he may still use cocaine. **S**
6. **Harm reduction, safety and family**. Fentanyl contaminates much of the illicit stimulant supply, and people who do not use opioids have died of it; naloxone and test strips are essential. He has no suicidal or homicidal ideation and no access to firearms, and he is safe to treat as an outpatient with weekly visits. Family can help, but only with his consent and on his terms. **S**

## Recommendations

1. Start aripiprazole 5 mg each morning; check weight, blood pressure, akathisia and abnormal movements at each visit, glucose and lipids at four months if still on it, and taper gradually after about six weeks of remission.
2. Contingency management with twice-weekly urine tests and prize draws for twelve weeks, and weekly cognitive behavioral therapy.
3. No medicine for cocaine use disorder for now; avoid stimulant-based options.
4. Home blood pressure readings before the four-week visit; if hypertension is confirmed, a calcium channel blocker or thiazide first, an echocardiogram for left ventricular hypertrophy that also measures the aortic root, and no beta-blocker while he may use cocaine.
5. Call 911 for chest pain, shortness of breath, weakness, or tearing pain in the chest or back.
6. Repeat the MoCA once he has been well for some weeks; no traumatic encephalopathy syndrome or chronic traumatic encephalopathy label.
7. Keep naloxone and fentanyl test strips at home, never use alone, and come back without shame after any use.
8. Review safety at every visit, with the 988 Suicide & Crisis Lifeline in his phone.
9. Involve family only if and when he chooses, with a signed release.
10. Social work for his money worries.

## Strengths and supports

- Strengths and supports: the discipline of a long athletic career, generosity toward others, pride in his Army service and in what his career meant to many people, a quiet dignity and humor, friends from boxing and the Army, and his own decision to come in after the collapse **S**

## Communication

Discussed with Dr. Achterberg-Cole, who saw him the same day. The diagnosis and options were explained to Mr. Louis in plain words; he chose to start aripiprazole and contingency management today. **S**

## Follow-up

Dr. Achterberg-Cole continues the visits and prescribing; addiction psychiatry will see him again if psychotic symptoms persist beyond a month without cocaine or return after the taper, if he uses cocaine repeatedly, or if he wants to discuss a medicine. **S**

## Guideline basis

- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023), American Society of Addiction Medicine and American Academy of Addiction Psychiatry (Journal of Addiction Medicine 2024;18(1S Suppl 1):1-56)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020), American Psychiatric Association (American Journal of Psychiatry 2020;177(9):868-872)
- Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021), Substance Abuse and Mental Health Services Administration
- Opioid Overdose Reversal Medications (2026), Substance Abuse and Mental Health Services Administration
- National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021), Neurology 2021;96(18):848-863
- Racial disparities in psychotic disorder diagnosis: A review of empirical literature (2014), World Journal of Psychiatry 2014;4(4):133-140
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
